G39S (p.Gly39Ser) variant of MS4A1 (B-lymphocyte antigen CD20)

G39S (p.Gly39Ser) in MS4A1 (B-lymphocyte antigen CD20) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes population frequency data and structural context.

G39S (p.Gly39Ser) variant details